Dr. Suvash Shrestha, MD

Dr. Shrestha practices at Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham.

Dr. Shrestha's NPI, 1184065161, was assigned on July 8, 2013. Dr. Shrestha holds New Hampshire license 24081.

Dr. Shrestha's primary practice is Wentworth-Douglass Hospital, at 789 Central Ave, Dover, NH 03820 in Strafford County. The practice phone is (603) 740-2580.

Dr. Shrestha's primary practice is Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham. Dr. Shrestha is also affiliated with Brigham and Women's Hospital. The medical group on file is Wentworth-Douglass Hospital. Dmand AI also links Dr. Shrestha to 2 more hospitals, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shrestha practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Shrestha's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Shrestha's licenses on file in 2 states: New Hampshire and Rhode Island.

CMS data shows 1,765 Medicare services from Dr. Shrestha across 18 procedure codes in 2024, for 852 Medicare patients. Medicare paid $73,256 for them.

CMS counts 852 Medicare patients who saw Dr. Shrestha in 2024. The largest group is 75 to 84, with 361 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shrestha's median patient age at 72, with 52% women.

In 2024, Dr. Shrestha wrote 904 Medicare Part D claims for 187 patients. 87% of them were for generic drugs. CMS names the drug for 788 of them, across 18 drugs with 11 or more claims each, at $105,463 in total drug cost. In 2017, CMS named 13 claims across 1 drug.

Dr. Shrestha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Shrestha, published from 2016 to 2023. 2016 was the busiest year, with 3. Dr. Shrestha has published most often in Cureus. Dr. Shrestha's most frequent co-authors are Felix Yang, MD, Jinu Jacob John, MD and On Chen, MD.

CMS Open Payments shows 27 general payments to Dr. Shrestha from 9 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 50% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $503.